Clinical Trials Logo

Insulin Resistance clinical trials

View clinical trials related to Insulin Resistance.

Filter by:

NCT ID: NCT02586168 Completed - Insulin Sensitivity Clinical Trials

The Effect of Gemcabene on Insulin Sensitivity in Nondiabetic Subjects

Start date: July 2001
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine the effect of gemcabene on insulin sensitivity as defined by average glucose disposal rate.

NCT ID: NCT02585830 Completed - Obesity Clinical Trials

Sleep Timing and Insulin Resistance in Adolescents With Obesity

Start date: October 2015
Phase:
Study type: Observational

This study examines the relationship between sleep timing and insulin resistance in adolescents with obesity. The investigators also aim to develop a physiologically-based mathematical model of adolescent sleep/wake and circadian interactions.

NCT ID: NCT02582606 Completed - Insulin Resistance Clinical Trials

Meal Pattern and Metabolic Parameters

Start date: February 2014
Phase: N/A
Study type: Interventional

In this study investigators will compare the health effect of two different meal patterns. In one, participants will consume food according to an 'irregular meal pattern' (minimum 3 meals, maximum 9 meals per day) and in the other 'regular meal pattern' (6 meals per day) for two weeks. The energy requirement of the participants will be calculated to maintain body weight during the study. Participants will be provided with all the food to be consumed during the study. Initially, interested individuals will attend a screening visit in which they will complete questionnaires on medical health, eating habits and physical activity. Height, weight and waist circumference will be measured at this visit. Thereafter, participants will be assigned to a 2-week period following one of the two meal-patterns. There will be a 2-week period between the two interventions when they will consume their normal diet and at the end of this, participants will undertake the next meal pattern. During the two phases participants will be asked to wear an armband (which detects movement and measures heat loss), to assess their energy expenditure and an interstitial glucose monitoring device will be worn for seven days. Before and after each 2-week intervention, participants will come to the laboratory for a mixed-meal tolerance test. Blood samples will be obtained before and for 3hrs after eating to evaluate the health effects of the meal patterns. Energy expenditure will be measured by ventilated-hood indirect calorimetry and the armband device. At the end of the 3hr post prandial period, participants will be offered an ad libitum pasta lunch and be asked to eat until they feel comfortably full. During each of the 2-week periods, participants will be asked to record their food intake and record their appetite sensations on specific days.

NCT ID: NCT02580513 Completed - Clinical trials for Diabetes Mellitus, Type 2

Circadian Misalignment and Insulin Sensitivity

Start date: January 2016
Phase: N/A
Study type: Interventional

This study will evaluate the effect of circadian misalignment on insulin sensitivity in healthy lean subjects in a randomized cross-over design. Subjects will be admitted to the research facility for two study periods of 3 and 3.5 days. In one of the study periods, the behavioral cycle will be shifted by 12 hours. Insulin sensitivity will be measured with a hyperinsulinemic euglycemic clamp.

NCT ID: NCT02565862 Completed - Diabetes Mellitus Clinical Trials

A Drug-drug Interaction Study Between Daclatasvir and Metformin

DATE-3
Start date: January 2016
Phase: Phase 1
Study type: Interventional

This study aims to provide clinical information on a potential drug-drug interaction between daclatasvir and metformin.

NCT ID: NCT02539355 Completed - Obesity Clinical Trials

Diet and Metabolic Inflammation

Start date: August 2015
Phase: N/A
Study type: Interventional

Obesity is a risk factor for several common cancers, including those of the breast, colon, liver, and pancreas. Proposed molecular links between obesity and these types of cancer include systemic inflammation, hyperinsulinemia, and changes in the serum concentrations of sex steroid hormones and adipokines. All of these are strongly linked to low-grade chronic inflammatory processes in expanded adipose tissue. The objective of this proposal is to test the hypothesis that adipose tissue inflammation can be reduced by the foods we eat.

NCT ID: NCT02535832 Completed - Clinical trials for Rheumatoid Arthritis

Skeletal Muscle Dysfunction in Rheumatoid Arthritis (RA)

Start date: September 2015
Phase: Phase 1
Study type: Interventional

Muscle strength helps determine a person's quality of life and functional independence. Patients with rheumatoid arthritis often suffer from muscle weakness and a pre-diabetic condition called insulin resistance. By doing this study, the investigators hope to learn why patients with rheumatoid arthritis (RA) suffer from muscle weakness.

NCT ID: NCT02521025 Completed - Insulin Resistance Clinical Trials

Bedrest, Feeding Pattern, and Insulin Sensitivity

Start date: October 2015
Phase: N/A
Study type: Interventional

In the present study, the investigators will assess the impact of two different feeding patterns (continuous vs intermittent) on insulin sensitivity and muscle mass following bedrest.

NCT ID: NCT02519543 Completed - Bipolar Disorder Clinical Trials

Treating Insulin Resistance as a Strategy to Improve Outcome in Refractory Bipolar Disorder

TRIO-BD
Start date: September 2015
Phase: Phase 3
Study type: Interventional

In a previous study by Dr. Calkin, the principal investigator of this study, persons with bipolar disorder and either type II diabetes or insulin resistance were found to experience more severe symptoms of bipolar illness and a lower response to treatment, compared to persons with bipolar disorder who did not have type II diabetes or insulin resistance. To further explore these findings, the investigators have developed this study to see if treating insulin resistance (using metformin, a drug used to improve the body's use of insulin) may also help improve the symptoms of bipolar illness.

NCT ID: NCT02517307 Completed - Normal Volunteers Clinical Trials

Fatty Acid Oxidation Defects and Insulin Sensitivity

Start date: February 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to learn more about what causes insulin resistance. It has been suggested that proper breakdown of fat into energy (oxidation) in the body is important to allow insulin to keep blood sugar in the normal range. The investigators want to know if having one of the fatty acid oxidation disorders could have an influence on insulin action. Fatty acid oxidation disorders are genetic disorders that inhibit one of the enzymes that converts fat into energy. The investigators will study both normal healthy people and people with a long-chain fatty acid oxidation disorder.